Jun 18 |
Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial
|
Jun 18 |
Autonomix appoints Brad Hauser as CEO
|
Jun 17 |
Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer
|
Jun 6 |
This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management
|
Jun 3 |
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial
|
May 23 |
Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer
|
May 14 |
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
|
Apr 25 |
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip
|
Apr 24 |
Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
|
Apr 16 |
Autonomix gets patent covering proprietary catheter-based technology
|